Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Are the Latest Market Insights for the Methenamine Hippurate Tablets Industry?
In recent times, there has been a significant expansion in the market size of methenamine hippurate tablets. The market is predicted to increase from $9.52 billion in 2024 to $10.11 billion in 2025, showcasing a compound annual growth rate (CAGR) of 6.2%. The surge in growth during the historic period can be credited to traditional UTI treatment methods, worries over antibiotic resistance, clinical confirmations, the prescription habits of physicians, and a patient inclination for non-antibiotic alternatives.
In the coming years, the market size for methenamine hippurate tablets is projected to experience substantial growth, reaching “$13.47 billion in 2029 with a compound annual growth rate (CAGR) of 7.4%. Factors contributing to this growth during the forecast period include the rising incidence of UTIs, heightened concerns about antibiotic resistance, advancements in managing UTIs, a healthcare emphasis on preventive treatments, as well as clinical studies and research. The forecast period is expected to see trends such as an increase in UTI cases, the escalation of antibiotic resistance, a preference for non-antibiotic remedies, preventive healthcare attention, and research and development efforts.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9412&type=smp
What Forces Are Driving The Growth Of The Methenamine Hippurate Tablets Industry?
The growth of the methenamine hippurate tablets market is anticipated to be spurred by a rising elderly population. This designates individuals aged 60 and above, who are more prone to urinary tract infections due to factors such as reduced urine flow, prostate enlargement, or kidney stones. Hence, there is a need for methenamine hippurate tablets to treat these conditions. For example, the World Health Organization, a specialized body of the United Nations based in Switzerland and oversees international public health, predicts that by 2030, one in six people worldwide will be 60 or older. As of 2022, there were 1.4 billion individuals over the age of 60. By 2050, the global number of individuals aged 60 or above will have doubled to 2.1 billion. Those who are 80 or older are expected to triple in number, reaching 426 million. Thus, the escalating population of the elderly is fuelling the expansion of the methenamine hippurate tablets market.
What Is The Overview Of Market Segmentation In The Methenamine Hippurate Tablets Industry?
The methenamine hippurate tablets market covered in this report is segmented –
1) By Type: 20 Tablets Or Bottle, 6 Tablets Or Bottle
2) By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy
3) By Application: Uncomplicated UTIs, Healthcare-associated UTIs
4) By End User: Hospitals, Homecare, Specialty Clinics, Others End Users
Subsegments:
1) By 20 Tablets per Bottle: Standard Packaging, Bulk Packaging Options
2) By 6 Tablets per Bottle: Standard Packaging, Sample Or Trial Packaging
What Notable Trends Are Shaping The Direction Of The Methenamine Hippurate Tablets Market?
The introduction of innovative products is a leading trend in the methenamine hippurate tablets market that is gaining traction. To solidify their standing in the market, major corporations in the methenamine hippurate tablets sector are launching novel products. For example, EQL Pharma, a European pharmaceutical firm that focuses on developing and selling economically viable generic medications and unique generics to pharmacies and hospitals, announced the off-licensing of Memprex (methenamine hippurate) to Laboratoires Majorelle for the French market in May 2023. This move broadens its accessibility and provides a non-antibiotic alternative for UTI prevention. Laboratoires Majorelle, a well-known company in the sphere of women’s health in France, will market and distribute Memprex, providing a non-antibiotic UTI prevention option.
Who Are The Primary Players Operating Across The Global Methenamine Hippurate Tablets Market?
Major companies operating in the methenamine hippurate tablets market include Alvogen Lux Holdings S.ÀR.L., Micro Labs Inc., Aurobindo Pharma, Amneal Pharmaceuticals Inc., Viatris Inc., McKesson Corporation, Sun Pharmaceutical Industries Ltd., Cipla Ltd., Dr. Reddy’s Laboratories Ltd., Cadila Healthcare Ltd., Torrent Pharmaceuticals Ltd., Glenmark Pharmaceuticals Ltd., Zydus Pharmaceuticals Ltd., Lupin Ltd., Alkem Laboratories Ltd., Ipca Laboratories Ltd., Granules India Ltd., Teva Pharmaceutical Industries Ltd., Apotex Pharmachem Inc., Sandoz International GmbH
Get The Full Report Here:
https://www.thebusinessresearchcompany.com/report/methenamine-hippurate-tablets-global-market-report
Which Region Offers The Most Growth Potential For The Methenamine Hippurate Tablets Market Through 2029?
North America was the largest region in the methenamine hippurate tablets market in 2024. The regions covered in the methenamine hippurate tablets market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=9412&type=smp
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model